Status:
TERMINATED
The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes
Lead Sponsor:
University of Florida
Conditions:
Gestational Diabetes Mellitus in Pregnancy
Eligibility:
FEMALE
18-50 years
Brief Summary
The thought is that Non-Alcoholic Fatty Liver Disease (NAFLD) plays a key role in the progression to prediabetes/T2DM in those with a history of Gestational Diabetes (GDM). The investigators want to k...
Detailed Description
A liver ultrasound will be completed during the last trimester of pregnancy along with a questionnaire. The questionnaire includes baseline maternal characteristics, age, race, ethnicity, parity, bloo...
Eligibility Criteria
Inclusion
- a pregnant female
- age between 18-50 years.
Exclusion
- pregravid diabetes mellitus
- inability to understand and speak English
- inability to provide consent
- plans to relocate out of the area within 12 months postpartum
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT01855386
Start Date
January 1 2013
End Date
September 1 2018
Last Update
November 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shands Medical Plaza
Gainesville, Florida, United States, 32608